3845I-FREEK MOBILE

3849NIPPON TECHNO LAB

9904Verite

6982The Lead

6676MELCO HOLDINGS

3950THE PACK

3293AZUMA HOUSE

2404TETSUJIN

4304Estore

3968Segue Group

6656inspec

6640DAI-ICHI SEIKO

3808OKWAVE

9787AEON DELIGHT

2735WATTS

8925ARDEPRO

4674CRESCO

6294OKADA AIYON

8938GLOME Holdings

6625JALCO Holdings

2492Infomart

1430First-corporation

4284SOLXYZ

8179ROYAL HOLDINGS

3490Azplanning

6912KIKUSUI ELECTRONICS

6881KYODEN

1904TAISEI ONCHO

2174GCA

6616TOREX SEMICONDUCTOR

6240YAMASHIN-FILTER

3277Sansei Landic

6837KYOSHA

3916Digital Information Technologies

3393Startia Holdings

3196HOTLAND

3837Ad-Sol Nissin

1446CANDEAL

7771Nihon Seimitsu

7810Crossfor

5805SWCC SHOWA HOLDINGS

6157NS TOOL

4760ALPHA

3918PCI Holdings

3097The Monogatari Corporation

6073ASANTE

4572Carna Biosciences

2586FRUTA FRUTA

3237INTRANCE

9740CENTRAL SECURITY PATROLS

3401Teijin

4293SEPTENI HOLDINGS

4662Focus Systems

3294e'grand

4310Dream Incubator

1431Lib Work

3030HUB

8920TOSHO

9997BELLUNA

3689IGNIS

6750ELECOM

3753FLIGHT HOLDINGS

6547GREENS

4745Tokyo Individualized Educational Institute

4381BPLATS

8737Akatsuki Corp

2488JAPAN THIRD PARTY

3387create restaurants holdings

2362YUMESHIN HOLDINGS

8918LAND

3113Oak Capital

8732MONEY PARTNERS GROUP

2767FIELDS

3276Japan Property Management Center

6835Allied Telesis HD

2702Mcdonald's Holdings(Japan)

4563AnGes

6460SEGA SAMMY HOLDINGS

6175Net Marketing

5704JMC

3652Digital Media Professionals

2384SBS Holdings

9531TOKYO GAS

9857EIWA

2749JP-HOLDINGS

7463ADVAN

9517eREX

6890Ferrotec Holdings

3845I-FREEK MOBILE

3849NIPPON TECHNO LAB

9904Verite

6982The Lead

6676MELCO HOLDINGS

3950THE PACK

3293AZUMA HOUSE

2404TETSUJIN

4304Estore

3968Segue Group

6656inspec

6640DAI-ICHI SEIKO

3808OKWAVE

9787AEON DELIGHT

2735WATTS

8925ARDEPRO

4674CRESCO

6294OKADA AIYON

8938GLOME Holdings

6625JALCO Holdings

2492Infomart

1430First-corporation

4284SOLXYZ

8179ROYAL HOLDINGS

3490Azplanning

6912KIKUSUI ELECTRONICS

6881KYODEN

1904TAISEI ONCHO

2174GCA

6616TOREX SEMICONDUCTOR

6240YAMASHIN-FILTER

3277Sansei Landic

6837KYOSHA

3916Digital Information Technologies

3393Startia Holdings

3196HOTLAND

3837Ad-Sol Nissin

1446CANDEAL

7771Nihon Seimitsu

7810Crossfor

5805SWCC SHOWA HOLDINGS

6157NS TOOL

4760ALPHA

3918PCI Holdings

3097The Monogatari Corporation

6073ASANTE

4572Carna Biosciences

2586FRUTA FRUTA

3237INTRANCE

9740CENTRAL SECURITY PATROLS

3401Teijin

4293SEPTENI HOLDINGS

4662Focus Systems

3294e'grand

4310Dream Incubator

1431Lib Work

3030HUB

8920TOSHO

9997BELLUNA

3689IGNIS

6750ELECOM

3753FLIGHT HOLDINGS

6547GREENS

4745Tokyo Individualized Educational Institute

4381BPLATS

8737Akatsuki Corp

2488JAPAN THIRD PARTY

3387create restaurants holdings

2362YUMESHIN HOLDINGS

8918LAND

3113Oak Capital

8732MONEY PARTNERS GROUP

2767FIELDS

3276Japan Property Management Center

6835Allied Telesis HD

2702Mcdonald's Holdings(Japan)

4563AnGes

6460SEGA SAMMY HOLDINGS

6175Net Marketing

5704JMC

3652Digital Media Professionals

2384SBS Holdings

9531TOKYO GAS

9857EIWA

2749JP-HOLDINGS

7463ADVAN

9517eREX

6890Ferrotec Holdings

What's New
New Analyst Reports
Information

What's New

  • 11/11/2019NEW
  • Nihon Seimitsu(7771)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Japan Property Management Center(3276)
  • Summary of Business Results for the Third Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Estore(4304)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • eREX(9517)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • 11/08/2019
  • DAI-ICHI SEIKO(6640)
  • Financial Results for the Third Quarter of the Fiscal Year Ending December 31, 2019 [Japan GAAP] (Consolidated)
  • WATTS(2735)
  • Notice Regarding October 2019 Monthly YoY Change in Sales and Number of Shops
  • FIELDS(2767)
  • Financial Briefing Material for the First Half of the Year Ending March 31, 2020
  • Fact Book (Supplementary Financial Document for the First Half of the Year Ending March 31, 2020)
  • Focus Systems(4662)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Non-consolidated)
  • Startia Holdings(3393)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • JALCO Holdings(6625)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • The Lead(6982)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Non-consolidated)
  • The Monogatari Corporation(3097)
  • Summary of Business Results for the First Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Carna Biosciences(4572)
  • Financial Results FY2019 Q3
  • Consolidated Financial Results for the Third Quarter of the Year Ending December 31, 2019 [Japanese GAAP]
  • ASANTE(6073)
  • October Monthly Sales Report for FY Ending March 2020
  • Mcdonald's Holdings(Japan)(2702)
  • Overview of Consolidated Financial Results for the Nine Months Ended September30, 2019
  • Consolidated Financial Results for the Nine Months Ended September 30, 2019
  • 11/07/2019
  • FIELDS(2767)
  • Summary of Financial Information and Consolidated Business Results for the First Half of the Year Ending March 31, 2020
  • KYODEN(6881)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • INTRANCE(3237)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • GCA(2174)
  • Updated Track Record on our WEB site : Advisor to Architect Equity on its $50M inaugural capital raise
  • 11/06/2019
  • YAMASHIN-FILTER(6240)
  • Consolidated Financial Results for the Second Quarter Ended September 30, 2019 [Japan GAAP]
  • CRESCO(4674)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Ad-Sol Nissin(3837)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Non-consolidated)
  • ELECOM(6750)
  • Summary of Financial Results for the second quarter 2020
  • Mcdonald's Holdings(Japan)(2702)
  • Monthly IR News
  • THE PACK(3950)
  • Summary of Financial Results for the third quarter 2019
  • ASANTE(6073)
  • Financial Results for the Second Quarter Ended September 30, 2019 - Supplementary Material
  • [Summary] Summary of Business Results for the Second Quarter Ended September 30, 2019
  • 11/05/2019
  • SWCC SHOWA HOLDINGS(5805)
  • Notice of Revision to Consolidated Full-year Business Forecasts for the Fiscal Year Ending March 2020
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • 11/01/2019
  • Dream Incubator(4310)
  • Summary of Consolidated Financial Results for the Six Months Ended September 30, 2019 (Based on Japanese GAAP)
  • YUMESHIN HOLDINGS(2362)
  • Notice Concerning Status of Acquisition of Treasury Stock
  • Teijin(3401)
  • Flash Report - Results of FY2019 2Q & Outlook for FY2019 -
  • Consolidated Financial Statements Summary (For the six months ended September 30, 2019)
  • 10/31/2019
  • ARDEPRO(8925)
  • Regarding Controlling Shareholders of the Company
  • NS TOOL(6157)
  • Analyst Report (Shared Research) : Released Q2 FY03/20 results
  • SBS Holdings(2384)
  • Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY12/19 [Report Update]
  • NIPPON TECHNO LAB(3849)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Non-consolidated)
  • GLOME Holdings(8938)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • SOLXYZ(4284)
  • Summary of Business Results for the Third Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • GREENS(6547)
  • Summary of Business Results for the First Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • NS TOOL(6157)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Infomart(2492)
  • Summary of Business Results for the Third Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • Teijin(3401)
  • Notice Regarding Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2021
  • Notice Regarding Dividends from Surplus (Interim Dividend)
  • e'grand(3294)
  • Notice Concerning Dividend Payment from Retained Earnings (Interim Dividend)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Non-consolidated)
  • SEGA SAMMY HOLDINGS(6460)
  • FY Ending March 2020 2Q Results Presentation
  • FY Ending March 2020 2Q Results / Appendix
  • FLASH REPORT CONSOLIDATED FINANCIAL STATEMENTS [Japanese GAAP] 6 Months Ended September 30, 2019
  • 10/30/2019
  • MELCO HOLDINGS(6676)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • MONEY PARTNERS GROUP(8732)
  • Summary of Business Results for the Second Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • HOTLAND(3196)
  • Summary of Business Results for the Third Quarter Ended September 30, 2019 [Japan GAAP] (Consolidated)
  • TOKYO GAS(9531)
  • Financial Results for FY2019 2Q ended September 2019
  • GCA(2174)
  • Updated Track Record on our WEB site : Advisor to Hitachi Power Solutions on its sale of the analysis contract service business to Endeavour United
  • 10/29/2019
  • AEON DELIGHT(9787)
  • Analyst report(Shared Research) : Interview following the Announcement of Financial Results for Q2 FY02/20[Report Update]
  • 10/28/2019
  • Ad-Sol Nissin(3837)
  • Notice of Revisions to Business Forecasts for the Six Months of the Current Fiscal Year
  • AnGes(4563)
  • Consolidated Financial Report for the 9 Months Ended September 30, 2019
  • 10/24/2019
  • Teijin(3401)
  • Notice Regarding Dividends Received from a Consolidated Subsidiary
  • GCA(2174)
  • Updated Track Record on our WEB site : Advisor to OpenSlate on its strategic investment from Nielsen Holdings
  • Updated Track Record on our WEB site : Advisor to Dataxu on its acquisition by Roku
  • 10/21/2019
  • Tokyo Individualized Educational Institute(4745)
  • Questions and Answers Session with Institutional Investors (FY2/20 Q2 Results)
  • 10/18/2019
  • ADVAN(7463)
  • Results for 2Q of the fiscal year ending March 2020
  • ARDEPRO(8925)
  • Notice Concerning Settlement of the Sales Contract for Real Estate for Sale
  • GCA(2174)
  • Updated Track Record on our WEB site : Advisor to the shareholders of Virosac on a club deal sale of the company organized by Orienta Partners and Indigo Capital
  • 10/17/2019
  • Ferrotec Holdings(6890)
  • Notice of Merger between Our Subsidiaries and Change of Company Name of Surviving Company
  • IGNIS(3689)
  • Analyst report(Shared Research): The company announced a business alliance between its consolidated subsidiary, Pulse Inc., and Monobit Morikatron Holdings, as well as a capital investment in Monobit Morikatron Holdings [Report Update]
  • 10/16/2019
  • The Monogatari Corporation(3097)
  • Notice Regarding September 2019 Preliminary Monthly YoY Change in Sales and Number of Restaurants
  • GCA(2174)
  • Updated Track Record on our WEB site : Advisor to LeanTeq on its sale to EnPro Industries
  • 10/15/2019
  • WATTS(2735)
  • Operating Results for the Fiscal Year Ended August 2019 and Business Forecasts for the Fiscal Year Ending August 2020
  • Startia Holdings(3393)
  • Analyst report(Walden Research Japan)
  • Dream Incubator(4310)
  • Notice Regarding the Transfer of Assets and Business
  • ALPHA(4760)
  • FY Aug-2019 Fact Sheet
  • Japan Property Management Center(3276)
  • Quartery Report (July to September) of FY December-2019
  • GCA(2174)
  • Updated Track Record on our WEB site : < Business Succession Deal > Advisor to Nireco Corporation on its acquisition of Kogakugiken Corporation
  • Latest Presentations

    Latest Video&Slides

    Company news
    provided by Timely Disclosure Network

    News Release

    Stock Code or Name:

    4507   Shionogi & Co.,Ltd.

    11/01/2019 16:00 Notice Regarding the Status (Progress Report) of Acquisition of Own Shares
    10/31/2019 09:00 1st Half of Fiscal 2019 Financial Results
    10/30/2019 18:40 Shionogi Announces Commencement of Tender Offer for Certificates of Shares, Etc. in UMN Pharma Inc.(Securities Code: 8840)
    10/30/2019 13:00 1st Half of Fiscal 2019 Financial Results
    10/30/2019 13:00 Financial Results for the Second Quarter of Fiscal Year 2019(Consolidated)
    10/28/2019 15:00 Update on the Japanese Association for Infectious Diseases Statement and Revised Guidelines of the Japanese Pediatric Society for the Treatment of Flu
    10/18/2019 15:00 FDA Approves XOFLUZA(TM) for the Treatment of Acute Uncomplicated Influenza for People at High Risk of Developing Influenza-Related Complications
    10/17/2019 10:00 U.S. FDA Advisory Committee Recommends Approval of Cefiderocol for Treatment of Complicated Urinary Tract Infections
    10/16/2019 15:00 Shionogi Filed for the Supplemental New Drug Application of XOFLUZA(R) in Japan for the Post-Exposure Prophylaxis of Influenza Virus Infection
    10/03/2019 09:00 Shionogi Reports Positive Results from Cefiderocol Phase III Study in Adults with Pneumonia Caused by Gram-negative Pathogens
    10/02/2019 11:30 Congress Presentation on Clinical Study of S-600918, a Drug Candidate for the Treatment of Refractory/Unexplained Chronic Cough
    09/30/2019 13:00 Notice Regarding Acquisition of Own Shares and Cancellation of Treasury Shares
    09/02/2019 15:00 Special Drug Use Survey for XOFLUZA(R) Announced at OPTIONS X
    09/02/2019 15:00 The Results of Analyses of PA/I38X-substituted Viruses in XOFLUZA(R) Clinical Studies
    09/02/2019 15:00 Positive Results for XOFLUZATM Global Phase III Study (MINISTONE-2)in Children with Influenza
    09/02/2019 15:00 Shionogi Announces Post-Exposure Prophylaxis Results for XOFLUZA(R) in PhaseIII Study (BLOCKSTONE) of Influenza Virus Infection in Household Members
    08/29/2019 11:30 Shionogi Announces XOFLUZA Tablets 20mg for The Treatment of Influenza Types A and B in Patients 12 years of Age and older Approved in Taiwan.
    07/29/2019 13:00 Financial Results for the First Quarter of Fiscal Year 2019 (Consolidated)
    07/29/2019 13:00 Financial Results for the First Quarter of Fiscal Year 2019
    07/29/2019 13:00 1st Quarter of Fiscal 2019 Financial Results Conference Call
    07/22/2019 16:10 Shionogi announces out-licensing agreement with AMR Centre on COT-143,a humanized monoclonal antibody targeting the PcrV protein of P. aeruginosa
    07/19/2019 09:00 Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
    07/01/2019 15:00 Corporate Governance Report 2019
    06/24/2019 11:00 Shionogi Concludes Licensing Agreements with Eddingpharm and EOC Pharma for Lusutrombopag, a Thrombopoietin Receptor Agonist and Epertinib, an HER2/EG
    06/19/2019 15:15 SHIONOGI AND FERRER CONCLUDE A CONTRACT FOR THE PROMOTION IN SPAIN OF RIZMOIC(R) (NALDEMEDINE), A THERAPEUTIC AGENT FOR OPIOID-INDUCED CONSTIPATION
    06/18/2019 17:00 Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan
    06/18/2019 17:00 Announcement about the Adjustment of the Conversion Value for Euro-Yen Denominated Convertible Bonds Maturing in 2019
    06/13/2019 14:00 Shionogi Purchases All Outstanding Shares of Pionnier following the Conclusion of their Joint Study
    06/04/2019 15:00 Shionogi Announces Positive Top-Line Results for XOFLUZA(R) (Baloxavir Marboxil) Phase III Study (BLOCKSTONE)
    05/23/2019 08:00 Items Disclosed on Internet Concerning Notice of Convocation Annual General Meeting 2019
    05/23/2019 08:00 Notice of Convocation Annual General Meeting 2019
    05/22/2019 15:15 SHIONOGI AND MOLTENI CONCLUDE A CONTRACT FOR THE COMMERCIALIZATION OF RIZMOIC(R)(NALDEMEDINE)
    05/10/2019 09:00 FY2018 Financial Results (April 2018 March 2019)
    05/09/2019 13:20 Financial Results for the year ended March 31,2019
    05/09/2019 13:20 FY2018 Financial Results(April 2018-march 2019)
    05/09/2019 13:20 Financial Results for Fiscal Year 2018 (Consolidated)
    04/22/2019 13:00 Notice of Revisions to Dividend Forecasts
    04/11/2019 15:15 SHIONOGI Concludes a Contract for the Commercialization of Rizmoic(R)(naldemedine),in Germany, the UK, and the Netherlands
    04/11/2019 08:30 Shionogi Announces Licensing of Symproic(R)(naldemedine) to BioDelivery Sciences International Inc.
    04/01/2019 15:00 Shionogi Announces the Commencement of its Operations of Shionogi Pharma Co., Ltd.
    04/01/2019 15:00 SHIONOGI ANNOUNCES SUBMISSION OF CEFIDEROCOL MARKETING AUTHORISATION APPLICATION
    03/14/2019 10:25 presentation material of R&D meeting of FY2018
    03/07/2019 16:00 Akili and Shionogi Announce Strategic Partnership to Develop and Commercialize Digital Therapeutics in Key Asian Markets
    03/06/2019 15:00 FDA Accepts XOFLUZA(TM) (Baloxavir Marboxil) Supplemental New Drug Application
    02/28/2019 13:00 Shionogi enters into Comprehensive Cooperation Agreement in the Field of Infectious Desease Focused on Malaria with Nagasaki University.
    02/20/2019 15:00 Notice Regarding Completion of Cancellation of Treasury Shares
    01/31/2019 13:00 Notice Regarding Changes of Cancellation of Treasury Shares
    01/31/2019 13:00 3rd Quarter of Fiscal 2018 Financial Results Conference Call
    01/31/2019 13:00 Financial Results for the Third Quarter of Fiscal Year 2018(Supplement)
    01/31/2019 13:00 Financial Results for the Third Quarter of Fiscal Year 2018(Consolidated)
    01/23/2019 15:00 Shionogi Announces Agreements on Collaborative Research with PeptiDream for New Peptide Drug Conjugate(PDC) Discovery
    12/21/2018 18:30 Coorporate Governance Report
    12/21/2018 15:00 Notice Regarding the Status and Completion of Acquisition of Own Shares
    12/19/2018 08:30 Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization
    12/14/2018 15:00 Notice Regarding the Status (Progress Report) of Acquisition of Own Shares
    12/06/2018 11:30 SHIONOGI Invests in Vast Therapeutics forFuture In-lisence of Nitric Oxide Inhaled Antimicrobial Drug Candidate